FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q2 2016 13F Holders as of 30 Jun 2016
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 14,071,764
- Share change
- -1,743,802
- Total reported value
- $23,921,000
- Price per share
- $1.70
- Number of holders
- 37
- Value change
- -$3,087,760
- Number of buys
- 11
- Number of sells
- 22
Quarterly Holders Quick Answers
What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31189P102:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.5%
|
4,307,485
|
$7,753,000 | — | 31 Mar 2016 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
2%
|
2,473,186
|
$4,452,000 | — | 31 Mar 2016 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
1.8%
|
2,257,920
|
$4,064,000 | — | 31 Mar 2016 | |
| Redmile Group, LLC |
13F
|
Company |
1.2%
|
1,486,980
|
$2,677,000 | — | 31 Mar 2016 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.57%
|
692,900
|
$1,247,000 | — | 31 Mar 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.52%
|
635,475
|
$1,144,000 | — | 31 Mar 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.41%
|
500,000
|
$900,000 | — | 31 Mar 2016 | |
| Belmont Global Advisors, Inc. |
13F
|
Company |
0.39%
|
482,000
|
$868,000 | — | 31 Mar 2016 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.39%
|
474,537
|
$854,000 | — | 31 Mar 2016 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.24%
|
293,900
|
$529,000 | — | 31 Mar 2016 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
0.23%
|
285,953
|
$515,000 | — | 31 Mar 2016 | |
| Lombard Odier Asset Management (USA) Corp |
13F
|
Company |
0.2%
|
249,374
|
$449,000 | — | 31 Mar 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.18%
|
222,700
|
$401,000 | — | 31 Mar 2016 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.17%
|
204,447
|
$368,000 | — | 31 Mar 2016 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.16%
|
197,329
|
$355,000 | — | 31 Mar 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.14%
|
173,924
|
$313,000 | — | 31 Mar 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
108,029
|
$194,000 | — | 31 Mar 2016 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.08%
|
96,500
|
$174,000 | — | 31 Mar 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0.06%
|
69,394
|
$125,000 | — | 31 Mar 2016 | |
| Spark Investment Management LLC |
13F
|
Company |
0.05%
|
63,700
|
$114,000 | — | 31 Mar 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
63,428
|
$114,000 | — | 31 Mar 2016 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
61,141
|
$110,000 | — | 31 Mar 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.05%
|
59,871
|
$108,000 | — | 31 Mar 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.04%
|
43,455
|
$78,000 | — | 31 Mar 2016 | |
| RUSSELL FRANK CO/ |
13F
|
Company |
0.03%
|
39,300
|
$71,000 | — | 31 Mar 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
36,697
|
$66,000 | — | 31 Mar 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
28,228
|
$51,000 | — | 31 Mar 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
25,531
|
$46,000 | — | 31 Mar 2016 | |
| Nationwide Fund Advisors |
13F
|
Company |
0.02%
|
22,578
|
$41,000 | — | 31 Mar 2016 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.02%
|
22,000
|
$40,000 | — | 31 Mar 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
20,002
|
$36,000 | — | 31 Mar 2016 | |
| Creative Planning |
13F
|
Company |
0.01%
|
17,000
|
$31,000 | — | 31 Mar 2016 | |
| Hochman Cole Investment Advisors, Inc. |
13F
|
Company |
0.01%
|
16,341
|
$29,000 | — | 31 Mar 2016 | |
| WEDBUSH SECURITIES INC |
13F
|
Company |
0.01%
|
11,500
|
$21,000 | — | 31 Mar 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.01%
|
8,811
|
$16,000 | — | 31 Mar 2016 | |
| BlackRock Japan Co. Ltd |
13F
|
Company |
0%
|
5,909
|
$11,000 | — | 31 Mar 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
4,327
|
$8,000 | — | 31 Mar 2016 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
4,000
|
$7,000 | — | 31 Mar 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,263
|
$6,000 | — | 31 Mar 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,127
|
$4,000 | — | 31 Mar 2016 | |
| Walleye Trading LLC |
13F
|
Company |
0%
|
1,300
|
$2,000 | — | 31 Mar 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,000
|
$2,000 | — | 31 Mar 2016 | |
| D.A. DAVIDSON & CO. |
13F
|
Company |
0%
|
720
|
$1,000 | — | 31 Mar 2016 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q2 2016
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2016 Across Filers
| Investor | Q1 2016 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2016 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.